COMP <GO>
NHI vs JPM // EV/EBITDA & P/E VALUATION
National Health Investors Inc. (NYSE) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: NHI 5
— JPM 4
■ METRIC PARITY
LAST: $66.95 (+1.93%) • MKT CAP: $3.29B
valuation
—
LAST: $343.58 (+1.26%) • MKT CAP: $913.30B
valuation
9.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NHI VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NHI | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.30% | 17.37% | -8.07 | JPM | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 9.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.75% | -18.14% | +16.39 | NHI | /fcf-yield <GO> |
| Operating Margin | — | 42.07% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 32.63% | +35.37 | NHI | /net-margins <GO> |
| Revenue Growth (YoY) | 47.10% | 13.53% | +33.57 | NHI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.16% | 1.96% | +3.20 | NHI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 2/9 | +3.00 | NHI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 4.84% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.6 | 55.1 | -3.48 | JPM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.00 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.4x | 13.6x | +5.83 | JPM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.29B | $913.30B | -$910.01B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NHI REV | JPM REV | NHI GROSS % | JPM GROSS % | NHI FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $80.1M | $182.45B | — | — | -$57.5M | -$147.78B |
| FY 2024 | $54.4M | $177.56B | — | — | $49.8M | -$42.01B |
| FY 2023 | $48.8M | $158.10B | — | — | $184.4M | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NHI // BETA —
JPM // BETA 1.00